股本结构
单位：万股
| 公告日期 | 2025-08-04 | 2025-05-29 | 2025-02-20 | 2025-02-13 | 2025-02-13 | 2025-03-21 |
|---|---|---|---|---|---|---|
| 证券总股本 | 1876.36 | 1706.36 | 1667.96 | 1647.96 | 1396.14 | 1281.71 |
| 普通股本 | 1876.36 | 1706.36 | 1667.96 | 1647.96 | 1396.14 | 1281.71 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-08-05 | 2025-05-27 | 2025-02-20 | 2025-02-13 | 2025-02-11 | 2024-12-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-08-04 | 1876.36 | 未披露 |
更多>>
Ordinary Shares offered 1,700,001 Shares by the company.
|
2025-08-05 |
| 2025-05-29 | 1706.36 | 未披露 | 定期报告 | 2025-05-27 |
| 2025-02-20 | 1667.96 | 未披露 | 定期报告 | 2025-02-20 |
| 2025-02-13 | 1647.96 | 未披露 |
更多>>
Ordinary Shares offered 2,518,182 Shares by the company.
|
2025-02-13 |
| 2025-02-13 | 1396.14 | 未披露 | 定期报告 | 2025-02-11 |
| 2025-03-21 | 1281.71 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Exercise of pre-funded warrants and consultants warrants
Exercise of warrants A
|
2024-12-31 |
| 2024-09-03 | 1116.25 | 未披露 |
更多>>
From December 31, 2023 to June 30, 2024
Exercise of pre-funded warrants and consultant warrants
Stock based compensation
Comprehensive loss
|
2024-06-30 |
| 2024-03-21 | 1080.66 | 未披露 | 定期报告 | 2024-03-11 |
| 2024-03-21 | 1007.40 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Conversion of convertible note into ordinary shares
Issuance of ordinary shares and warrants upon initial public offering, net of issuance costs
Issuance of ordinary shares, pre-funded warrants, and warrants upon private placement, net of issuance costs
|
2023-12-31 |
| 2023-12-19 | 718.88 | 未披露 | 定期报告 | 2023-12-18 |
| 2023-07-27 | 605.24 | 未披露 | 定期报告 | 2023-07-27 |
Ordinary Shares offered 1,700,001 Shares by the company.
Ordinary Shares offered 2,518,182 Shares by the company.
From December 31, 2023 to December 31, 2024
Exercise of pre-funded warrants and consultants warrants
Exercise of warrants A
From December 31, 2023 to June 30, 2024
Exercise of pre-funded warrants and consultant warrants
Stock based compensation
Comprehensive loss
From December 31, 2022 to December 31, 2023
Conversion of convertible note into ordinary shares
Issuance of ordinary shares and warrants upon initial public offering, net of issuance costs
Issuance of ordinary shares, pre-funded warrants, and warrants upon private placement, net of issuance costs